LYNN A. TETRAULT Insider Trading $NEO NEOGENOMICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LYNN A. TETRAULT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LYNN A. TETRAULT. LYNN A. TETRAULT is Director in NEOGENOMICS INC ($NEO) and Director in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
LYNN A. TETRAULT in NEOGENOMICS INC
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of LYNN A. TETRAULT: Director
Holdings: 34,939 shares
Current Value: $280,910
Latest Transaction: Jun 14 2021
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LYNN A. TETRAULT in NEOGENOMICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 9.11 | 1,389 | 12,654 | 0 | |
| Jun 14 2021 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 9.11 | 1,389 | 12,654 | 34,939 | 33.6 K to 34.9 K (+4.14 %) |
| Jun 01 2020 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
| Jun 01 2020 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 2,698 | 0 | 44,351 | 41.7 K to 44.4 K (+6.48 %) |
| Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
| Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 22.52 | 4,269 | 96,138 | 4,269 | |
| Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 3,419 | 0 | 41,653 | 38.2 K to 41.7 K (+8.94 %) |
| Jun 10 2019 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 3,419 | 0 | 41,653 | 38.2 K to 41.7 K (+8.94 %) |
| Nov 21 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 15.97 | 2,000 | 31,940 | 38,234 | 40.2 K to 38.2 K (-4.97 %) |
| Nov 21 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 16.00 | 11,000 | 176,000 | 40,234 | 51.2 K to 40.2 K (-21.47 %) |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 7.27 | 3,333 | 24,231 | 6,667 | |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 9.11 | 5,555 | 50,606 | 2,778 | |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | M | 6.66 | 10,000 | 66,600 | 0 | |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Sell | S | 16.16 | 5,000 | 80,800 | 51,234 | 56.2 K to 51.2 K (-8.89 %) |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 7.27 | 3,333 | 24,231 | 56,234 | 52.9 K to 56.2 K (+6.30 %) |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 9.11 | 5,555 | 50,606 | 52,901 | 47.3 K to 52.9 K (+11.73 %) |
| Nov 16 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 6.66 | 10,000 | 66,600 | 47,346 | 37.3 K to 47.3 K (+26.78 %) |
| Jun 05 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 11.60 | 3,017 | 34,997 | 3,017 | |
| Jun 05 2018 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 0.00 | 15,564 | 0 | 37,346 | 21.8 K to 37.3 K (+71.45 %) |
| May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 8,667 | 0 | 8,667 | |
| May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 7.27 | 10,000 | 72,700 | 10,000 | |
| May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 5,072 | 0 | 0 | |
| May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | C | 0.00 | 2,150 | 0 | 0 | |
| May 30 2017 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | M | 0.00 | 7,222 | 0 | 21,782 | 14.6 K to 21.8 K (+49.60 %) |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 9.11 | 8,333 | 75,914 | 25,555 | |
| Jul 29 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 0.00 | 5,072 | 0 | 7,222 | |
| May 03 2016 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Grant | A | 7.15 | 2,150 | 15,373 | 16,710 | 14.6 K to 16.7 K (+14.77 %) |
| Dec 23 2015 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | P | 8.21 | 9,500 | 77,995 | 14,560 | 5.1 K to 14.6 K (+187.75 %) |
| Dec 09 2015 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Buy | P | 7.72 | 3,500 | 27,020 | 5,060 | 1.6 K to 5.1 K (+224.36 %) |
| Jul 15 2015 | NEO | NEOGENOMICS INC | TETRAULT LYNN A. | Director | Option Exercise | A | 6.66 | 10,000 | 66,600 | 10,000 |
Page: 1